Search General Info
Search Education
Search Partnering Companies

Paul Aliu, MBA, MRPharmS, PharmD

Basel, Switzerland
Paul is the Global Head of Medical Governance within the cross-divisional Chief Medical Office at Novartis, with responsibility for the oversight, standards, training and systems for compassionate use/expanded access and post-registration medical programs (e.g. Investigator initiated trials, non-interventional studies, registries, local studies and research collaborations). He has worked in the pharmaceutical industry for almost 20 years in multiple roles in drug development, medical affairs and program management covering therapeutic areas such as oncology, rheumatology, transplantation, infectious and tropical diseases. Prior to joining the pharmaceutical industry he trained and practiced as a clinical pharmacist.

He served as an industry representative on the WHO/Roll-Back Malaria (RBM) case management working group, managed various partnerships (Public-Private & Private-Private) and has participated in multiple stakeholder discussions on Global Health, Compassionate Use/Expanded Access and Patient Access.

Paul is a member of the Royal Pharmaceutical Society of Great Britain (MRPharmS). He has a doctorate in Clinical Pharmacy (PharmD) from the University of Florida, a first class honours masters degree in Pharmacy (MPharm) from the Sunderland School of Pharmacy in the UK, a qualifying Law degree from the College of Law (now University of Law) in London, a certificate in Global Health Delivery from Harvard University, and an executive MBA from the International Institute for Management Development (IMD) in Lausanne, Switzerland.
Speaking In
9:00 AM - 9:55 AM (PDT)
Thursday, June 11
The pace of a medical crisis (not only a pandemic like coronavirus, but a more focal but lethal…